Virtus Health (ASX:VRT) Stock Crosses Above Fifty Day Moving Average of $4.82

Virtus Health Ltd (ASX:VRT) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $4.82 and traded as high as $4.22. Virtus Health shares last traded at $4.22, with a volume of 92,638 shares trading hands.

The company has a 50-day simple moving average of A$4.80 and a 200-day simple moving average of A$4.29. The company has a debt-to-equity ratio of 60.79, a quick ratio of 0.59 and a current ratio of 0.66. The stock has a market cap of $339.25 million and a P/E ratio of 12.06.

The firm also recently disclosed a Final dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, October 25th will be given a $0.12 dividend. The ex-dividend date is Thursday, October 3rd. This represents a yield of 3.01%. Virtus Health’s payout ratio is 68.57%.

In other Virtus Health news, insider Sonia Petering acquired 22,000 shares of the business’s stock in a transaction on Wednesday, August 28th. The stock was purchased at an average price of A$3.97 ($2.81) per share, for a total transaction of A$87,318.00 ($61,927.66).

About Virtus Health (ASX:VRT)

Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services.

Read More: Why do corrections happen?

Receive News & Ratings for Virtus Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus Health and related companies with MarketBeat.com's FREE daily email newsletter.